Swirl gently in a slow circular motion until fully dissolved
Cramp frequency and severity were higher in females of the present study, consistent with previous studies [3, 14, 15]
Blagosklonny 2009
Branded medications go through rigorous FDA review, offer consistent dosing, and come with established safety data from large clinical trials
Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, shows dose-dependent nausea rates, ranging from approximately 12-18% at lower doses to higher rates at doses used for weight management, as demonstrated in the SURPASS-2 trial comparing it with semaglutide
Kashima Y, Miki T, Shibasaki T et al (2001) Critical role of cAMP-GEFIIRim2 complex in incretin-potentiated insulin secretion